MMCAP International’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21K Hold
175,000
﹤0.01% 211
2025
Q4
$54.3K Hold
175,000
0.01% 154
2025
Q3
$50.8K Buy
+175,000
New +$47.4K 0.01% 128

Other funds holding TDACW

MMCAP International's TDACW Position: Q1 2026 in Review

MMCAP International held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 175,000 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #211.

MMCAP International first reported a position in TDACW in Q3 2025 and has held it in 3 quarters since. The position peaked at $54.3K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • MMCAP International held 175,000 shares of Translational Development Acquisition Corp Warrants worth $21K as of Q1 2026.
  • MMCAP International left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of MMCAP International's portfolio in Q1 2026, its #211 holding.
  • MMCAP International first reported a position in Translational Development Acquisition Corp Warrants in Q3 2025 and has held it in 3 quarters since.
  • MMCAP International's Translational Development Acquisition Corp Warrants position peaked at $54.3K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on MMCAP International's 13F filing for Q1 2026, filed 15 May 2026.